Skye Bioscience, Inc. (SKYE)
0.7526
+0.03
(+4.38%)
USD |
NASDAQ |
Feb 13, 14:13
Skye Bioscience Free Cash Flow : -41.53M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Assertio Holdings, Inc. | 13.33M |
| Eli Lilly & Co. | 6.436B |
| Theravance Biopharma, Inc. | 243.48M |
| Viking Therapeutics, Inc. | -278.68M |
| Kyntra Bio, Inc. | -17.14M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -13.36M |
| Cash from Investing (Quarterly) | 7.967M |
| Free Cash Flow Per Share (Quarterly) | -0.3369 |
| Free Cash Flow to Equity (Quarterly) | -13.32M |
| Free Cash Flow to Firm (Quarterly) | -13.36M |
| Free Cash Flow Yield | -138.9% |